The Singapore Hepatology Conference (SHC) 2024 is dedicated to clinical management of chronic Hepatitis B and C.
The Singapore Hepatology Conference (SHC) 2024 covers topics such as:
- Future treatments for HBV
- Evolving HBV therapy - combination and stopping NA
- DAA difficult to treat cases
- HCC debate: East vs West
- HCC immunotherapy
- DAA treatment failures and resistance
- Therapeutic advances in NASH
- Fatty liver disease in Asia
The Singapore Hepatology Conference (SHC) 2024 brings together attendees from:
- Scientists
- Medical doctors
- Trainees
